# Cann Social Tonic Financial Model Cann is a cannabis-infused "social tonic" positioned as a low-dose (2mg THC), health-conscious alternative to alcohol for mainstream/casual consumers. - Canonical: https://finamodel.com/startups/cann-social-tonic - Excel download: https://finamodel.com/startup-models/cann-social-tonic.xlsx - Category: Health-tech - Model type: Unit-economics / DTC - Geography: California (launch market). New Mexico referenced on some slides (CA / NM tags), suggesting near-term expansion plans. [DECK] ## About the company Cann is a cannabis-infused social tonic positioned as a low-dose, health-conscious alternative to alcohol. Its product is sold through regulated California dispensaries and built through digitally native brand and community marketing. The company has confirmed three flavours and relies on micro-influencers, celebrity support, and experiential events to build mainstream awareness. Regulated distribution makes retail availability and compliant supply key operating constraints. The model should forecast cases and units sold by SKU, wholesale price, dispensary coverage, COGS, and gross margin. Marketing, trade spend, production, inventory, and state-specific regulatory costs should be modelled explicitly. ## What's included - 5-year monthly revenue build with stage-appropriate growth assumptions - Full P&L, headcount plan, and operating-expense schedule - Cash-flow statement, runway, and burn-rate tracking - Valuation via exit multiple with a DCF cross-check - Returns analysis with MOIC and IRR - Unit economics including CAC, LTV, payback, and cohort retention ## Product & value proposition - Product: Cann Social Tonic - a canned, cannabis-infused sparkling beverage. - Dose: 2mg THC per can - the lowest in the beverage category vs. competitors at 5–100mg. - Calories: 30 cals per can vs. 100–150 cals for comparable social drinks (gin & tonic ~100, White Claw ~110, Bud Light ~110, Magners ~150). - Flavors: Blood Orange Cardamom, Grapefruit Rosemary, Lemon Lavender. - Attributes: Non-GMO, no stevia, no artificial flavors, no gluten. - Onset: Quick sublingual absorption - uses heuristics from alcohol (drink more than one, gradual controllable build). - Target consumer: "Canna-Casual" and "Canna-Curious" segments - mainstream adults who currently use alcohol but are seeking healthier social alternatives. ## Market - Low-dose cannabis (≤5mg) is the fastest-growing sub-segment: 2–3x growth vs. all cannabis products. - Low-dose Colorado growth reached 83% by end of 2017 (source: RBC Capital Markets Equity Research, August 2018). - 33% of today's cannabis market is low-dose; projected to be 70%+ by 2023 if growth trends continue. - Addressable behaviour pool: 21 of 25 adult drinkers are trying to reduce or moderate alcohol consumption (source: Beverage Daily). ## Revenue model - Channel: Licensed cannabis retail dispensaries in California (regulated channel); digital/DTC social presence. - SKU count: 3 flavors confirmed. - Go-to-market: Digitally native brand - micro-influencer network → mainstream celebrity endorsements. Pop-up/experiential events. ## Traction & metrics - Instagram followers: 1,511 followers, 492 posts at time of deck. ## Competition / moat **Direct cannabis beverage competitors (shown in slide 8):** - Lagunitas Hi-Fi Hops: 5–10mg THC - Hop & Cola, California Dreamin', Sprig, Legal: 10–20mg THC - Cannabis Quencher, Dixie: 25–100mg THC - Cann: 2mg THC (lowest dose - clear white space) **Indirect competitors (alcohol substitutes, slide 7):** - Gin & tonic (~100 cals), White Claw (~110 cals), Bud Light (~110 cals), Magners (~150 cals) - Cann at 30 cals is positioned as materially healthier **Moat claims:** - Lowest dose in segment creates a distinct product category (approachable for non-users) - Sublingual fast-onset format (not edible) differentiates from slow/unpredictable gummies - Premium brand aesthetics targeting wellness-oriented mainstream consumer vs. "stoner" imagery - First-mover in mainstream cannabis social beverage positioning **Notable competitors cited as validation:** - Kiva Confections (Terra Blueberries, 5mg, #1 edible 2017 ERRL Cup) - Dosist (2.25mg/dose, Fast Company World's 50 most innovative companies 2018) ## Team & funding ask / use of funds **Founders:** - **Jake Bullock** (co-founder): PE, management consulting, IB background; cannabis venture investments; co-President Cannabis Business Club at Stanford GSB; worked at Besito (premium LA cannabis brand). Duke undergrad, Bain Capital, Stanford GSB. - **Luke Anderson** (co-founder): 6 years Bain & Company (consumer experience design, product marketing for large CPG); Architecture background; Teach For America; Harvard Business School. --- ## Recommended financial model - **Archetype + why:** DTC/CPG Revenue & Gross Margin P&L model, with a volume-based unit economics layer. Cann is a physical product brand in a regulated channel - the model needs to track cases/units sold, revenue per case (wholesale + DTC blended), COGS (production, co-packing, cannabis input), gross margin, and operating expenses (marketing, events, G&A). Not a SaaS or marketplace - no recurring subscription or platform take-rate. Closest analogue: consumer beverage startup P&L (e.g., Liquid Death, Olipop early-stage). - **Forecast horizon & granularity:** Monthly for Year 1–2 (pre-profitability, cash-sensitive), quarterly for Years 3–5. 5-year total horizon. - **Key drivers & assumptions:** | Driver | Value | | ------- | ------ | | Launch state | California | | SKUs at launch | 3 flavors | | THC dose per can | 2mg | | Calories per can | 30 | | Retail price per can (MSRP) | ~$6–8 | | Wholesale price per can | ~$3.50–4.50 | | Case size (cans/case) | 24 | | Production COGS per can | ~$1.50–2.00 | | Gross margin (wholesale channel) | ~45–55% | | Retail door count Year 1 | 25–75 CA dispensaries | | Cases per door per month | 2–5 | | DTC / event revenue share | 10–15% of total | | S&M spend (% revenue) | 30–40% Year 1, declining to 15–20% by Year 3 | | G&A | $200K–$400K/yr Year 1 | | Geographic expansion (NM) | Year 2 | | Low-dose market CAGR | ~2–3x vs. total cannabis (i.e., ~40–60% annual) | - **Scenarios (Base / Bull / Bear - which variables flex):** - **Base:** 50 retail doors by end of Year 1, 3 cases/door/month, 3 flavors, CA only; NM added Year 2 - **Bull:** Faster door growth (150+ by Year 1 end), celebrity endorsement accelerates brand velocity, expanded to 3+ states by Year 2 - **Bear:** Slow dispensary adoption, regulatory friction slows expansion, low-dose segment doesn't achieve projected 70% market share; company stays CA-only through Year 2 - **Required sheets / outputs:** 1. **Assumptions** - all unit economics, pricing, and door-count inputs 2. **Revenue build** - doors × velocity × price, by channel (wholesale vs. event/DTC) and SKU 3. **COGS & gross margin** - production cost per unit, contribution margin per can/case 4. **Operating expenses** - S&M (influencer, events, billboard), G&A, headcount 5. **P&L (Income Statement)** - monthly Year 1–2, quarterly Year 3–5 6. **Cash flow & runway** - burn rate, implied funding need (no raise stated in deck) 7. **Market penetration** - CA dispensary door count vs. total addressable doors 8. **Sensitivity table** - retail doors × cases/door/month → revenue and gross profit ## Frequently asked questions ### Is the Cann Social Tonic financial model free? Yes. The Cann Social Tonic model is a free Excel download with live formulas. ### Can I change the assumptions? Yes. The workbook is editable and its live formulas recalculate when assumptions change.